Invesaro

Stocks Health care ALC

NYSE · Health care

Alcon Inc (ALC)

Alcon Inc reported revenue of $10.4B in fiscal 2025, up 4.9% from a year earlier. Net income was $980M, a net margin of 9.4%. Operating cash flow minus capital spending left $1.7B of free cash flow in fiscal 2025. At December 31, 2025 it held $1.5B in cash against $4.7B of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on February 24, 2026.

Price
$64.47
-0.14% on the day · September 25, 2026
52-week range $61.84 to $87.64
Market cap
$32.2B
Revenue (FY2025)
$10.4B
+4.9% year on year
Net margin
9.4%

What Alcon Inc does

Alcon Inc is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NYSE under the ticker ALC.

Revenue and profit by year

Revenue
FY19: $7.2B $7.2B FY19FY19: $7.5B $7.5B FY19FY20: $6.8B $6.8B FY20FY21: $8.3B $8.3B FY21FY22: $8.7B $8.7B FY22FY23: $9.5B $9.5B FY23FY24: $9.9B $9.9B FY24FY25: $10.4B $10.4B FY25
Net income
FY19: -$227M -$227M FY19FY19: -$656M -$656M FY19FY20: -$531M -$531M FY20FY21: $376M $376M FY21FY22: $335M $335M FY22FY23: $974M $974M FY23FY24: $1B $1B FY24FY25: $980M $980M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$10.4B$1.4B$980M$1.98$1.7B
2024$9.9B$1.4B$1B$2.05$1.6B
2023$9.5B$1B$974M$1.96$730M
2022$8.7B$672M$335M$0.68$581M
2021$8.3B$580M$376M$0.76$645M
2020$6.8B-$482M-$531M-$1.09$344M

Latest SEC filings

What Alcon Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 10, 2026
    Foreign issuer update 6-K
  2. May 15, 2026
    Conflict minerals disclosure SD
  3. May 5, 2026
    Foreign issuer update 6-K
  4. April 2, 2026
    Foreign issuer update 6-K
  5. February 24, 2026
    Foreign issuer update 6-K
  6. February 24, 2026
    Annual report (foreign issuer) 20-F · period to December 31, 2025
  7. February 24, 2026
    Foreign issuer update 6-K
  8. January 7, 2026
    Foreign issuer update 6-K
  9. December 9, 2025
    Form DFAN14A filing DFAN14A
  10. November 12, 2025
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on February 26, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about ALC

What does Alcon Inc do?

Alcon Inc is registered with the SEC under industry code SIC 3851 (Ophthalmic Goods). Its shares trade on NYSE under the ticker ALC.

Is Alcon Inc profitable?

Yes. In fiscal 2025 it reported net income of $980M on revenue of $10.4B, a net margin of 9.4%.

How much revenue does Alcon Inc make?

In fiscal 2025 Alcon Inc reported revenue of $10.4B. That is 4.9% more than a year earlier.

When did Alcon Inc last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on February 24, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from August 10, 2026.

Similar companies

BLCO
Bausch & Lomb Corp
COO
Cooper Companies, Inc.
EYE
National Vision Holdings, Inc.
WRBY
Warby Parker Inc.
STAA
Staar Surgical Co
RXST
RxSight, Inc.

Follow ALC

Get an email when Alcon Inc files with the SEC: results, executive changes, material agreements and annual reports.

Follow ALC: get an email when it files

Where the numbers come from

Financial figures are the values Alcon Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.